News & Analysis as of

Spain Regulatory Agenda

Jones Day

Spain's Draft Law on Collective Actions to Transpose EU Directive 2020/1828

Jones Day on

Spain is moving forward with transposition of the EU Representative Actions Directive, aiming to unify rules and strengthen consumer protection....more

Jones Day

Game Changer: Green Light for Offshore Wind in Spain

Jones Day on

After years of delay, Spain's new regulation paves the way for offshore wind energy....more

White & Case LLP

AI Watch: Global regulatory tracker - Spain

White & Case LLP on

Spain creates Europe's first AI supervisory agency and actively participates in EU AI Act negotiations. Laws/Regulations directly regulating AI (the “AI Regulations”) Currently, there are no specific laws, statutory...more

White & Case LLP

Mercosur Trade Alert

White & Case LLP on

Chief negotiators from Mercosur and the European Union (EU) met in Brasilia, Brazil earlier this month to resume attempts to conclude an inter-regional free trade agreement (FTA) after new proposals from both sides tabled...more

BakerHostetler

DSIR Deeper Dive: Absent Legislation, Privacy Regulators Offer Guidance on AI

BakerHostetler on

By now, many of us are using AI, advising others about how to use AI, and waiting for some legislative miracle to give us some guardrails for what we can or cannot be doing with AI. A lot of effort has been put into tracking...more

McDermott Will & Emery

Investing in Healthcare & Life Sciences - An International Guide to Regulatory and Transactional Issues Across the Sector -...

McDermott Will & Emery on

As macroeconomic forces and geopolitical dynamics continue to shape the M&A and investment climate globally, health and life sciences transactions continue to remain high priority sectors presenting both high growth and...more

Hogan Lovells

Major regulatory changes in pharmaceutical laws and regulations in Spain for 2023

Hogan Lovells on

The Annual Regulatory Plan for 2023 recently released by the Spanish Government provides for important regulatory changes and developments in the area of medicinal products, including pricing and reimbursement or health...more

Hogan Lovells

Spain’s AEMPS clarifies position on hydroxychloroquine, echoing statements of EMA and Lancet

Hogan Lovells on

The Spanish Agency for Medicinal Products and Medical Devices (AEMPS) stated that it will not take, for the time being, any regulatory action to temporarily suspend or halt the recruitment of patients for clinical trials to...more

Hogan Lovells

New medical device regulation in Spain opened for public consultation

Hogan Lovells on

Spain’s Ministry of Health initiated proceedings for approval of the new regulation on medical devices with a call for a prior public consultation to receive contributions from interested parties....more

Hogan Lovells

Spain: Contingency measures following no-deal Brexit published –and they guarantee continuity of insurance contracts and smooth...

Hogan Lovells on

What is all about? Brexit month is finally here –or is it? Interests at stake on both sides of the Channel, fearing consequences of a no-deal Brexit, may end up cristalysing in a delay and extension to Article 50 of the TFEU....more

10 Results
 / 
View per page
Page: of 1

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide